Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals

Medical Electron Microscopy

Volumn 35, Issue 4, 2002, Pages 179-203

  Takahashi, Kiyoshi ^a   Takeya, Motohiro ^b   Sakashita, Naomi ^b  

^a Fuji Bio Co Ltd   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesterol ester; Foam cells; Lipoproteins; Monocytes; Scavenger receptors

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CEROID; CHEMOTACTIC FACTOR; CHOLESTEROL ESTER; COLONY STIMULATING FACTOR 1; CYTOKINE; GROWTH FACTOR; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOACCUMULATION; BLOOD CLOTTING; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELL; DISEASE COURSE; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYME SYNTHESIS; FIBRINOLYSIS; FOAM CELL; HUMAN; INFLAMMATORY CELL; INTERNALIZATION; INTIMA; LIPID STORAGE; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIOSCLEROSIS; CELL COMMUNICATION; HUMANS; IMMUNITY; LIPOPROTEINS, LDL; MACROPHAGES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS A;

EID: 0036995812     PISSN: 09184287     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007950200023     Document Type: Review

References (268)

1. Antischkow N (1914) Über die Atherosklerose der Aorta beim Kaninchen and über deren Entstehungsbedingungen. Beitr Pathol Anat Allg Pathol 59:306-348
2. Ross R (1993) Atherosclerosis: defense mechanisms gone awry. Am J Pathol 143:987-1002
3. Ross R (1993) The pathogenseis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
4. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
5. Raines EW, Rosenfeld ME, Ross R (1996) The role of macrophages. In: Fuster V, Ross R, Topol EJ (eds) Atherosclerosis and coronary disease, vol. 1. Lippincott Raven, Philadelphia, pp 39-55
6. Ruan Y, Takahashi K, Naito M (1995) Immunohistochemical detection of macrophage-derived foam cells and macrophage colony-stimulating factor in pulmonary atherosclerosis of cholesterol-fed rabbits. Pathol Int 45:185-195
7. Rosenfeld RE, Ross R (1990) Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic rabbits. Arteriosclerosis 10:680-687
8. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breshow JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353
9. Zhang SH, Reddick RL, Fiedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 256:468-477
10. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93:1885-1893
11. van Furth R (1989) Origin and turnover of monocytes and macrophages. In: Iverson O (ed) Cell kinetics of inflammatory reaction. Springer, Berlin, pp 125-150
12. Takahashi K (2001) Development and differentiation of macrophages and related cells: historic review and current concepts. J Clin Exp Hematopathol 41:1-32
13. Heidenreich S (1999) Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 65:737-743
14. Kiener PA, Davies PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, Liles WC (1997) Differential induction of apoptosis by Fas-Fas ligand interaction in human monocytes and macrophages. J Exp Med 185:1511-1516
15. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R (1999) Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19:2364-2367
16. Eihage R, Clamens S, Besnard S, Mallat Z, Tedgui A, Arnai J-T, Maret A, Bayard F (2001) Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 156:315-320
17. Liu Y, Hulten LM, Wiklund O (1997) Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol 17:317-323
18. Pinderski Oslund LJ, Hedrick CC, Hagenbaugh A, Territo M, Berliner JA, Fyfe AI (1999) Interleukin-10 blocks atherosclerosis events in vivo and in vitro. Arterioscler Thromb Vasc Biol 19: 2847-2853
19. Reckless J, Rubin EM, Verstuyft JB, Metcalf JC, Grainger DJ (1999) Monocyte chemoattractant protein-1 but not tumor necrosis factor-α is correlated with monocyte infiltration in mouse lipid lesions. Circulation 99:2310-2316
20. von Hundelshausen P, Weber KSC, Huo Y, Proudfoot AEI, Nelson PJ, Ley K, Weber C (2001) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103:1772-1777
21. Takeya M, Yoshimura T, Leonard EJ, Takahashi K (1993) Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 24:535-539
22. Cushing SD, Berliner JA, Valente AJ, Torrito MC, Navab M, Parchami F, Gerrity R, Schwartz CJ, Fogalman AM (1990) Minimally modified low density lipoprotein induces monocyte chemoattractant protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134-5138
23. Wang GP, Deng ZD, Ni J, Qu ZL (1997) Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages. Atherosclerosis 133:13-36
24. Tanaka Y, Adams DH, Shaw S (1993) Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14:111-115
25. Alello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM (1999) Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19:1518-1525
26. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor- deficient mice. Mol Cell 2:275-281
27. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897
28. Ni W, Egashira K, Kitamoto S, Kataoka C, Koyanagi M, Inoue S, Imaizumi K, Akiyama C, Nishida K-I, Takeshita A (2001) New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apoplipoprotein E-knockout mice. Circulation 103:2096-2101
29. Nageh MP, Sandberg ET, Marott KR, Lin AH, Melchior EP, Bullard DC, Beaudet AL (1997) Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 17:1517-1520
30. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR (1992) Expression of intracellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140:665-673
31. Bogen S, Pak J, Garifallou M, Deng X, Muller WA (1994) Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 179:1059-1064
32. Cybulsky MI, Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791
33. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN (1994) Increase in the adhesion molecule P-selectin in endothelium overlaying atherosclerotic plaques: coexpression with intracellular adhesion molecule-1. Am J Pathol 144:952-961
34. Zibara K, Chignier E, Covacho C, Poston R, Canard G, Hardy P, McGregor J (2000) Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient mice compared with wild-type mice. Arterioscler Thromb Vasc Biol 20:2288-2296
35. -/-) fed a fat or chow diet. Arterioscler Thromb Vasc Biol 20:3630-2635
36. Sakai A, Kume N, Nishi E, Tanoue K, Miyasaka M, Kita T (1997) P-selectin and vascular cell adhesion molecule-1 are focally expressed in aorta of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. Arterioscler Thromb Vasc Biol 17:310-316
37. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R (1998) Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18:842-851
38. 4 integrin and ICAM-1 markedly attenuates macrophage homing to atherosclerotic plaques in apoE-deficient mice. Circulation 97:75-81
39. Hynes RO, Wagner DD (1996) Genetic manipulation of vascular adhesion molecules in mice. J Clin Invest 98:2193-2195
40. Dong ZM, Brown AA, Wagner DD (2000) Prominent role of P-selectin in the development of advanced atherosclerosis in apoE-deficient mice. Circulation 101:2290-2295
41. Chester AH, O'Neil GS, Allen SP, Luu TN, Tadjkarimi S, Yacouh MH (1992) Effect of endothelin on normal and diseased human coronary arteries. Eur J Clin Invest 22:210-213
42. Ihling C, Gobel HR, Lippoldt A, Wessels S, Paul M, Schaefer HS, Zeiher AM (1996) Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol 179:303-308
43. Magazine HI, Andersen TT, Bruner CA, Malik AB (1994) Vascular contractile potency of endothelin-1 is increased in the presence of monocytes or macrophages. Am J Physiol 266: H1620-H1625
44. Pitt B (1994) Angiotensin-converting enzyme inhibitors inpatients with coronary atherosclerosis. Am Heart J 128:1328- 1332
45. Ysuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173-71178
46. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD (1998) Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation 98:800-807
47. Tummala PE, Chen X-L, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM (1999) Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature. A potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223-1229
48. Rosenfeld ME, Ylä-Herttuala S, Lipton AB, Ord VA, Witztum SL, Steinberg D (1992) Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 140:291-300
49. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P (1992) Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 140:301-316
50. Naito M, Hayashi S, Yoshida H, Nishikawa S, Shultz LD, Takahashi K (1991) Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Am J Pathol 139:657-667
51. Smith JD, Tragan E, Ginsberg M, Grigaux C, Tian J, Miyata M (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 92:8264-8268
52. Qiao J-H, Tripath J, Mishra NK, Triathi S, Wang X-P, Imes S, Fishbein MC, Clinton SK, Libby P, Rajavashisth TB (1997) Role of macrophage colony-stimulating factor in atherosclerosis. Am J Pathol 150:1687-1699
53. De Villiers WJS, Smith JD, Miyata M, Dansky HM, Barley E, Gordon S (1998) Macrophage phenotype in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Arterioscler Thromb Vasc Biol 18:631-634
54. Takahashi K, Naito M, Umeda S, Shultz LD (1994) The role of macrophage colony-stimulating factor in hepatic glucan-induced granuloma formation in the osteopetrosis mutant mouse defective in the production of macrophage colony-stimulating factor. Am J Pathol 144:1381-1392
55. Heinecke JW (1997) Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 8:268-274
56. Kita T, Nagano Y, Yokode M, Ishii K, Ooshima A, Yoshida H. Kawai C (1987) Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84:5928-5931
57. Neuzil J, Weber C, Kontush A (2001) The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 157:257-283
58. Staprans H, Rapp JH, Pan X-M, Hardman DA, Feingold KR (1996) Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 16:533-538
59. Staprans H, Pan X-M, Rapp JH, Grunfeld C, Feingold KR (2000) Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20:708-714
60. White CR, Brock TA, Chang L-Y, Crapo J, Brisco P, Ku D, Bradley WA, Gianturcoo SH, Gore J, Freeman BA, Tarpey MM (1994) Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 91:1044-1048
61. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC (2000) Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20:1529-1535
62. Tribble DL, Gong EL, Leuwenburgh C, Heinecke JW, Carlson EL, Verstuyft JG, Epstein CJ (1997) Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase. Arterioscler Thromb Vasc Biol 17:1734-1740
63. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, Steinberg D (1990) Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 87:6959-6963
64. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, Funk CD (1999) Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice. J Clin Invest 103:1597-1604
65. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD (2000) Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Circulation 103:2277-2282
66. Ishikawa K, Sugawara D, Wang X-P, Suzuki K, Itabe H, Maruyama Y, Luisis AJ (2001) Heme oxygenase inhibits atherosclerosis lesion formation in LDL-receptor knockout mice. Circ Res 88:506-512
67. Lee T-S, Shiao M-S, Pan C-C, Chau L-Y (1999) Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99:1222-1229
68. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacouh MH, Polak JM (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75:77-85
69. Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock J, Weikel R, Bergstromjb, Shevell DE, Hermanowski-Vosatka A, Sparrow CP, Chao Y-S, Radger DJ, Wrigh SD, Pure E (2000) Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 165:3430-3435
70. Niu X-L, Yang X, Hoshiai K, Tanaka K, Sawamura S, Koga Y, Nakazawa H (2001) Inducible nitric oxide synthase deficiency does not affect the susceptibility of mice to atherosclerosis but increases collagen content in lesions. Circulation 103:1115-1120
71. Ihrig M, Dangler CA, Fox JG (2001) Mice lacking inducible nitric oxide synthase develop spontanous hypercholesterolaemia and aortic atheromas. Atherosclerosis 156:103-107
72. De Villiers WJS, Fraser IP, Hughes DA, Doyle AG, Gordon S (1994) Macrophage colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 180:705-709
73. Hamilton JA, Myers D, Jessup W, Byrne R, Whitty G, Moss S (1999) Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 19:98-105
74. van der der Kooij MA, Morand OH, Kempen HJ, van Berkel TJC (1996) Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler Thromb Vasc Biol 16:106-114
75. Shindo J, Ishibashi T, Yokoyama K, Nakazato K, Ohwada T, Shiomi M, Maruyama Y (1999) Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits. Circulation 99:2150-2156
76. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaka T, Takano T (1994) A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. J Biol Chem 27:15274-15279
77. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T (1996) Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 37:45-53
78. Krieger M, Herz J (1994) Structure and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601-637
79. Kodama T, Doi T, Suzuki H, Takahashi K, Wada Y, Gordon S (1996) Collagenous macrophage scavenger receptor. Curr Opin Lipidol 7:287-291
80. Takahashi K, Takeya M, Sakashita N, Yoshimatsu M, Jinnouchi K (2001) The role of macrophage scavenger receptors in atherogenesis. In: Shoenfeld Y, Harats D, Wick G (eds) Atherosclerosis and autoimmunity. Elsevier Science, Amsterdam, pp 29-40
81. Fraser I, Highes D, Gordon S (1993) Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364:343-346
82. Geng Y-J, Kodama T, Hansson GK (1994) Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb 14:798-806
83. Gough PJ, Greaves DR, Gordon A (1998) A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL up-take. J Lipid Res 39:531-543
84. Naito M, Suzuki K, Mori T, Matsumoto A, Kodama T, Takahashi K (1992) Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141:591-599
85. Naito M, Kodama T, Matsumoto A, Doi T, Takahashi K (1991) Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am J Pathol 139:1411-1423
86. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynchi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijt JK, Berkel TJC, Steinberger UP, Ishibashi S, Maeda N, Gordon S, Kodama T (1997) A role for scavenger receptors in atherosclerosis and susceptibilty to infection. Nature 386:292-296
87. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Sakaguchi H, Kruijt JK, Higashi T, Suzuki T, Berkel TJ, Horiuchi S, Takahashi K, Yazaki Y, Kodama T (1997) The multiple roles of macrophage receptors (MSR) in vitro: resistance to atherosclerosis and susceptibility to infection in MSR knockout mice. J Atheroscler Thromb 4:1-11
88. Mori T, Takahashi K, Naito M, Kodama T, Hakamata H, Sasaki M, Miyazaki A, Horiuchi S, Ando M (1994) Endocytic pathway of scavenger receptors via trans-Golgi system in bovine alveolar macrophages. Lab Invest 71:409-416
89. Mori T, Takahashi K, Higashi T, Takeya M, Kume S, Kawabe Y, Kodama T, Horiuchi S (1995) Localization of advanced glycation end products of Maillard reaction in bovine tissues and their endocytosis by macrophage scavenger receptors. Exp Molec Pathol 63:135-152
90. Doi T, Kurasawa M, Higashino Y, Imanishi T, Mori T, Naito M, Takahashi K, Kawabe Y, Wada Y, Matsaumoto A, Kodama T (1994) The histidine interruption of an alpha-helical coiled coil allosterically mediates a pH-dependent ligand dissociation from macrophage scavenger receptors. J Biol Chem 269:25598-25604
91. Lougheed M, Moore EDW, Scriven DRI, Steinbrecher UP (1999) Uptake of oxidized LDL by macrophages differs from that of acetyl LDL and leads to expansion of an acidic endolysosomal compartment. Arterioscler Thromb Vasc Biol 19:1881-1890
92. Sakaguchi H, Takeya M, Suzuki H, Hakamata H, Kodama T, Horiuchi S, Gordon S, van der Laan JJW, Kraal G, Ishibashi S, Kitamura N, Takahashi K (1998) Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest 78:423-434
93. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K (1995) Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80:603- 609
94. Van der Laan LJW, Kangas M, Döpp EA, Brouge-Holub E, Elomaa O, Tryggvason K, Kraal G (1997) Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol Lett 57:203-208
95. Ito S, Naito M, Kobayashi Y, Takatsuka H, Jiang S, Umezu H, Hasegawa G, Arakawa M, Shultz LD, Elomaa O, Tryggvason K (1999) Roles of a macrophage receptor with collagenous structure (MARCO) in host defense and heterogeneity of splenic marginal zone macrophages. Arch Histol Cytol 62:83-95
96. Huh HY, Pearse SF, Yesner LM, Shinder JH, Silverstein RL (1996) Regulated expression of CD36 during monocyte-to-macrophage differentiation. Potential role of CD36 in foam cell formation. Blood 87:2020-2028
97. Han J, Hajjar DP, Febbriao M, Nicolson AC (1997) Native and modified low density lipoproteins increase in functional expression of the macrophage class B scavenger receptor CD36. J Biol Chem 272:21654-21659
98. Nakata A, Nakagawa Y, Nishida M, Nozaki S, Miyagawa I, Nakagawa T, Tamura R, Matsumoto K, Kamada-Takamura K, Yamashita S, Matsuzawa Y (1999) CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipidladen macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19:1333-1339
99. Nicolson AC, Han J, Febbriao M, Pearse SF, Gotto AM Jr, Hajjar DP (2001) CD36, the macrophage class B scavenger receptor: regulation and role in atherosclerosis. In: Shoenfeld Y, Harats D, Wick G (eds) Atherosclerosis and autoimmunity. Elsevier Science. Amsterdam, pp 41-47
100. Febbriao M, Podedrz EA, Smith JD, Hajjar DD, Hazen SL, Hoff HF, Sharma K, Silverstein RL (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105:1049-1056
101. Acton S, Rigotti A, Landschultz KT, Xu S, Hobbs HH (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:460-461.
102. Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antonucci M, Poulain P, Chapman J, Fruuchart J-C, Tedgui A, Najib-Fruchart J, Staels B (2000) CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101:2411-2417
103. Pearson A, Lux A, Krieger M (1995) Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor for Drosophila melanogaster. Proc Natl Acad Sci USA 92:4056-4060
104. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D (1995) The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92:9580-9584
105. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 93:14833-14838
106. Holness CL, da Silva RP, Fawcett J, Gordon S, Simmons DL (1993) Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J Biol Chem 268:9661-9666
107. Stanton LW, White RT, Bryant CM, Protter AA, Enddemann G (1992) A macrophage Fc receptor for IgG is also a receptor for oxidized low-density lipoprotein. J Biol Chem 267:22446-22451
108. Morganelli PM, Groveman DS, Fleifer JR (1997) Evidence that human Fc gamma receptor HA(CD32) subtypes are not receptors for oxidized LDL. Arterioscler Thromb Vasc Biol 17:3248-3254
109. Sawamura T, Kume N, Aoyama T, Moriwaki H, Horikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73-77
110. Moriwaki H, Kume N, Kataoka H, Murase T, Nishi E, Sawamura T, Masaki T, Kita T (1998) Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and mouse macrophages: upregulated expression by TNF-α. FEBS Lett 440:29-32
111. Adachi H, Tsujimoto M, Arai H, Inoue K (1997) Expression cloning of a novel scavenger receptor from human endothelial cells. J Biol Chem 272:31217-31220
112. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, Nagata I, Ando K, Nobuyoshi M, Hanyu M, Kameda M, Yonehara S, Kita T (2001) Expression of SR-PSOX, a novel cell-surface scavenger receptor for phophatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21:1796-1800
113. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Hensen PM (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90
114. Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cermack P, Stewart DJ (2000) Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor-deficient mice: role of endothelin in macrophage foam cell formation. Cardiovasc Res 48:158-167
115. Whitman SC, Miller DB, Wolfe BM, Hegele RA, Huff MM (1997) Uptake of type III hypertriglyceridemic VLDL by macrophages is inhanced by oxidation, especially after remnant formation. Arterioscler Thromb Vasc Biol 17:1707-1715
116. Gravfels ME, Paavola LG, Boyd DO, Nolan PM, Wittmack FM, Chawla A, Lazar MA, Buccan M, Angelin B, Strauss JF III (1994) Cloning of a complementary deoxyribonucleic acid encoding the murine homologue of the very low density lipoprotein receptor/apolipoprotien E receptor. Expression pattern and assignment of the gene to mouse chromosome 19. Endocrinology 135:387-394
117. Mulhaupt HAB, Gravfels ME, Kariko K, Jin H, Arens-Elliott C, Goldman BI, Strauss JF III, Angelin Warhot MJ, McCrea KR (1996) Expression of very low density lipoprotein receptor in the vascular wall. Am J Pathol 148:1985-1997
118. Nakazato K, Ishibashi T, Shindo J, Ahiomi M, Maruyama Y (1996) Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerosis. Am J Pathol 149:1831-1838
119. Fryman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J (1995) Normal plasma lipoproteins and fertility in gene-targeted mice homologous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci USA 92:8453-8457
120. Tacken PJ, Teusink B, Jong MC, Harats D, Havekes LM, Willems van Dijk K, Hofker MH (2000) LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice. J Lipid Res 41:2055-2062
121. Tacken PJ, Hofker MH, Havekes LM, Willems van Dijk K (2001) Living up to a name: the role of the VLDL receptor in lipid metabolism. Curr Opin Lipidol 12:275-279
122. Hiltunen TP, Luoma JS, Nikkari T, Ylä-Herttuala S (1998) Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions. Marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97:1079-1086
123. Jaakkola O, Ylä-Herttuala S, Sarkioja T, Nikkari T (1989) Macrophage foam cells from human aortic fatty streaks take up beta-VLDL and acetylated LDL in primary culture. Atherosclerosis 79:173-182
124. Koo C, Wernette Hammond ME, Garcia Z, Mallory MJ, Unauy R, East C, Bilheimer DW, Mahley RW (1988) The uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by the low density lipoprotein receptor. J Clin Invest 81:1332-1340
125. Perrey S, Ishibashi S, Kitamine T, Osuga J-I, Yagyu H, Chen Z, Shionoiri F, Izuka Y, Yahagi N, Yamura Y, Ohashi K, Harada K, Gotoda T, Yamada N (2001) The LDL receptor is the major pathway for β-VLDL uptake by mouse peritoneal macrophages. Atherosclerosis 154:51-60
126. Ellsworth JL, Kraemer FB, Cooper AD (1987) Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J Biol Chem 262:2316-2325
127. Herijgers N, van Eck M, Groot PHE, Hoogerbrugge PM, van Berkel TJC (1997) Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscler Thromb Vasc Biol 17:1995-2003
128. Herijgers N, van Eck M, Groot PHE, Hoogerbrugge PM, van Berkel TJC (2000) Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57BL/6 mice. Arterioscler Thromb Vasc Biol 20:1961-1967
129. 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269:375-382
130. 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. Am J Pathol 93:2014-2021
131. Llorente-Cortes V, Martinez-Gonalez J, Badimon L (2000) LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:1572-1579
132. Camps L, Reina M, Llobera M, Vilaro S, Olivecrona T (1990) Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol 258:C673-C681
133. Brunzell JD (1995) Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Vall D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 1913-1932
134. Zilversmit DB (1973) A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 33:633-638
135. O'Brien KD, Gordon D, Deeb S, Ferguson M, Chait A (1992) Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest 89:1544-1550
136. Mattsson L, Johansson H, Bondjers G, Wiklund O (1993) Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. J Clin Invest 92:1759-1765
137. Corey JE, Zilversmit DB (1977) Effect of cholesterol feeding on arterial lipolytic activity in the rabbit. Atherosclerosis 27:201-212
138. Benalian P, Luc de Gennes J, Foubert L, Zhang H, Gagne SE, Hayden M (1996) Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 335:848-854
139. Shimada M, Ishibashi S, Inaba T, Yagyu H, Harada K, Osuga J-I. Ohashi K, Yazaki Y, Yamada N (1996) Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci USA 93:7242-7246
140. Yagyu H, Ishibashi S, Chen Z, Osuga J-I, Okazaki M, Perrey S, Kitamine T, Shimada M, Ohashi K, Harada K, Shionoiri F, Yahagi N, Gotoda T, Yazaki Y, Yamada N (1999) Overexpressed lipoprotein lipase protects against atherosclerosis in apoplipoprotein E knockout mice. J Lipid Res 40:1677-1685
141. Clee SM, Bissada N, Miao F, Miao L, Marais AD, Henderson HE, Steures P, McManus J, McManus B, LeBoeuf RC, Kastelein JJ, Hayden MR (2000) Plasma
142. Stengel D, Antonucci M, Gaoua W, Dachet C, Lesnik P, Hourton D, Ninio E, Chapman MJ, Griglio S (1998) Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state. A key role for lysophosphatidycholine. Arterioscler Thromb Vasc Biol 18:1172-1180
143. Babaev VR, Fazio S. Gleaves JB, Radzioch O (1999) Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest 103:1697-1705
144. Wilson K, Fry GL, Chappell DA, Sigmund CD, Medh JD (2001) Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein E knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol 21:1809-1815
145. Zhang W-Y, Ishii I, Kruth H (2000) Plasmin-mediated macrophage reversal of low density lipoprotein aggregation. J Biol Chem 275:33176-33183
146. Bhakdi S, Dorweiler B, Kirchmann R, Torzewski J, Weise E, Tranum-Jensen J, Walev I, Wieland E (1995) On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogic moiety. J Exp Med 182: 1959-1971
147. + monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler Thromb Vasc Biol 21:1004-1010
148. Seifer PS, Hugo F, Tranum-Jensen J, Zahringer U, Muhly M, Bhakdi S (1990) Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J Exp Med 172:547-557
149. Torzewski M, Klouche M, Hock J, Messner M, Dorweiler B, Torzewski J, Gabbert HE, Bhakdi S (1998) Immunohistochemical demonstration of enzymatically modified LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol 18:369-378
150. Klouche M, May AE, Hemmes M, Messner M, Kanse SM, Preissner KT, Bhakdi S (1999) Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscler Thromb Vasc Biol 19:784-793
151. Schmiedt W, Kinscherf R, Deigner HP, Kamencic H, Nauen O, Kolo J, Oelert H, Metz J, Bhakdi S (1998) Complement 6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 18:1790-1795
152. Assmann G, Seedorf (2001) Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. 7th edn. McGraw-Hill, New York, pp 2363-2587
153. Ellender M, Chiumska A, Ledvinova J, Poupetova H (2000) Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma. Virchows Arch 436:82-87
154. Cummings MH, Watts GF (1995) Increased hepatic secretion of very low-density apolipoprotein B-100 in cholesteryl ester storage disease. Clin Chem 41:111-114
155. Brown MS, Ho YK, Goldstein JL (1980) The cholesterol ester cycle in macrophage foam cells: continual hydrolysis and reesterification of cytoplasmic cholesteryl esters. J Biol Chem 255:9344-9353
156. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH (1995) Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 270:5772-5778
157. Sakashita N, Miyazaki A, Takeya M, Horiuchi S, Chang CCY, Chang T-Y, Takahashi K (2000) Localization of human acylcoenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am J Pathol 156:227-236
158. Sakashita N, Miyazaki A, Chang CCY, Chang TY, Nakamura O, Kiyota E, Satoh M, Hori M, Horiuchi S, Takeya M (2002) The presence of acyl-coenzyme A: cholesterol acyltransferase-2 (ACAT-2) in human and mouse macrophages: evidence in vivo and in vitro. In: Abstract of the 3rd Conference on Arteriosclerosis, Thrombosis and Vascular Biology, Salt Lake City, April 6-8, p 287
159. Khelef N, Soe TT, Quenhenberger O, Beatini N, Tabas I, Maxfield FR (2000) Enrichment of acyl coenzyme A: cholesterol O-acyltransferase near trans-Golgi network and endocytic recycling compartment. Arterioscler Thromb Vasc Biol 20:1769-1776
160. Yagyu H, Kitamine T, Osuga J, Tozawa R, Chen Z, Kaji Y, Oka T, Perry S, Tamura Y, Ohashi K, Oazaki H, Yahagi H, Shionoiri F, Iizuka Y, Harada K, Shimano H, Yamashita H, Gotoda T, Yamada N, Ishibashi S (2000) Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 275:21324-21330
161. Accard M, Smith SJ, Newland DL, Sanan DA, King LE, Linton MF, Fazio S, Farese RV (2000) Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA: cholesterol acyltransferase 1. J Clin Invest 105:711-719
162. Kellner-Weibel G, Jerome WG, Small DM, Warner GJ, Stoltenborg JK, Keamey MA, Corjay MH, Phillips MVC, Rothblat GH (1998) Effects of intracellular free cholesterol accumulation on macrophage viability. A model for foam cell death. Arterioscler Thromb Vasc Biol 18:423-431
163. Kellner-Weibel G, Yancey PG, Jerome WG, Walser T, Mason RP, Phillips MC, Rothblat GH (1999) Crystallization of free cholesterol in model macrophage foam cells. Arterioscler Thromb Vasc Biol 19:1891-1898
164. Mazzone T (1996) Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr Opin Lipidol 7:303-307
165. 3. J Lipid Res 35:1345-1353
166. Basu SK, Goldstein JL, Brown MS (1983) Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. Science 219:871-873
167. Ghiselli G, Schaefer EJ, Gascon P, Breswer HBJr (1981) Type III hyperlioproteinemia associated with apolipoprotein E deficiency. Science 214:1239-1241
168. Rosenfeld ME, Butler S, Ord VA, Lipton BA, Dyer CA, Curtis LK, Palinski W, Witztum JL (1993) Abundant expression of apolipoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 13:1382-1389
169. Getz GS, Mazzone T, Soltys P, Bates SR (1988) Atherosclerosis and apolipoprotein E. An enigmatic relationship. Arch Pathol Lab Med 112:1048-1055
170. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Greaves LA, Atkinson JB, Linton MF (1997) Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94:4647-4657
171. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF (1999) The Tangier disease gene product ABC1 controls the cellular apoplipoprotein-mediated lipid removal pathway. J Clin Invest 104:R25-R31
172. Yakoyama S (1998) Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta 139:1-15
173. -/- mice. Arterioscler Thromb Vasc Biol 21:1790-1795
174. Hara H, Yokoyama S (1991) Interactions of free apolipoproteins with macrophages. J Biol Chem 266:352-355
175. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Ouelette BFF, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP, Genest J, Hayden MR (1999) Mutations in ABC1 in Tangier disease and familial high density lipoprotein deficiency. Nat Genet 22:336-345
176. Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DS, Goodman HC (1961) Tangier disease - combined staff conference at the National Institutes of Health. Ann Intern Med 55:1016-1031
177. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM (1991) Inhibition of early atherosclerosis in transgenic mice by human apolipoprotein AI. Nature 353:265-267
178. Rubin EM, Ishida BY, Clift SM, Krauss RM (1991) Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size classes. Proc Natl Acad Sci USA 88:434-438
179. Paszty C, Maeda N, Verstuyft J, Rubin EM (1994) Apolipoprotein AI transgene corrects apolipoprotein E-deficiency-induced atherosclerosis in mice. J Clin Invest 94:899-903
180. Benoit P, Emmanuel F, Caillaud J, Bassinet L, Castro G, Gallix P, Fruchart J, Branellec D, Denefle P, Duverger B (1999) Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models. Circulation 99:105-110
181. Argmann CA, van den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BW, Huff MW (2001) Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol 21:2011-2018
182. Sarig S, Utian WH, Sheean LA, Gorodeski GI (1995) Distribution of unesterified cholesterol-containing particles in human atherosclerotic lesions. Am J Pathol 146:139-147
183. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim H-M, Kitamura Y, Yutani C, Nomura S (1993) Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 143:1003-1008
184. Ling X, Sakashita N, Takeya M, Nagai R, Horiuchi S, Takahashi K (1998) Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues. Lab Invest 78:1591-1606
185. Mitchinson MJ, Hothersall DC, Brooks PN, De Burbure CY (1985) The distribution of ceroid in human atherosclerosis. J Pathol 145:177-183
186. Yin D (1996) Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 21:871-888
187. Yin D (1995) Studies on age pigments envolving into a new theory of biological aging. Gerontology 41 (Suppl 2):156-172
188. Mitchinson MJ, Ball RY, Carpenter KL, Eright JH (1990) Macrophages and ceroid in human atherosclerosis. Eur Heart J 11 (Suppl):116-121
189. Carpenter KL, van der Veen C, Taylor SE, Hardwick SJ, Clara K, Hegyi L, Mitchinson MJ (1995) Macrophages, lipid oxidation, ceroid accumulation, and alpha-tocopherol depletion in human atherosclerotic lesions. Gerontology 41 (Suppl 2):53-67
190. Lee FY, Lee TS, Pan CC, Huang AL, Chasu LY (1998) Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 138:281-288
191. Li W, Yuan XM, Olsson AG, Brunk UT (1998) Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler Thromb Vasc Biol 18:177-184
192. 10 inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 21:585-593
193. Kume S, Takeya M, Mori T, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667
194. Ling X, Nagai R, Sakashita N, Takeya M, Horiuchi S, Takahashi K (2001) Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes. Lab Invest 81:845-861
195. Picard S (1995) Lipoprotein glyco-oxidation. Diabetes Metab 21:89-94
196. Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K Nagai R, Horiuchi S, Itabe H, Takano T (2000) In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Atherosclerosis 150:343-355
197. Sakata N, Uesugi N, Takebayashi S, Nagai R, Jono T, Horiuchi S, Takeya M, Itabe H, Takano T, Myint T, Taniguchi N (2001) Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Cardiovasc Res 49:466-475
198. Thornalley PJ (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44:1013-1023
199. Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S, Nakayama H (2001) CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 275:3195-3202
200. Ohgami N, Nagai R, Myazaki A, Ikemoto M, Arai H, Horiuchi S, Nakayama H (2001) Scavenger receptor class B type 1-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J Biol Chem 276:13348-13355
201. Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frieri L, Su DK, Vlassara H, Liu FT, Di Mario U (2001) Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J 115:2471-2479
202. Liao H-S, Kodama T, Geng Y-J (2000) Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol. Arterioscler Thromb Vasc Biol 20:1968-1975
203. Sakai M, Miyazaki A, Hakamata H, Sakai T, Yui S, Yamazaki M, Shichiri M, Horiuchi S (1994) Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 269:31430-31435
204. 2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol 17:300-309
205. 2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 19:2909-2917
206. Hulten LM, Lindmark K, Diczfalusy U, Bjorkhem I, Ottosson M, Liu Y, Brondjers G, Wiklund O (1996) Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest 97:461-468
207. Geng Y-J, Libby P (1995) Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme. Am J Pathol 147:251-266
208. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503
209. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman MJ, Rouis M (1999) Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinases-1 expression in cholesterol-loaded human macrophages. Relevance to stability of atherosclerotic plaque. Circulation 99:420-426
210. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Hemphries S (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hydridization. Proc Natl Acad Sci USA 88:8154-8158
211. Galis Z, Sukhova G, Kranzhofer R, Clark S, Libby P (1995) Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92:402-406
212. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijin DPV, Teepen H, van der Wal AC, Borst C (2000) Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteinases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150:245-253
213. 2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys 310:481-488
214. 2-dependent plaque instability. Circulation 104:921-927
215. Rouis M, Adamy C, Duverger N, Lesnik P, Horellou P, Moreau M, Emanuel F, Caillaud JM, Laplaud PM, Dachet C, Chapman MJ (1999) Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation 100:533-540
216. Robbie LA, Booth NA, Brown PAJ, Bennett B (1996) Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 16:539-545
217. Smith EB, Keen GA, Grant A, Stirk C (1990) Fate of fibrinogen in human arterial intima. Arteriosclerosis 10:263-275
218. Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH (1988) Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Haemost 14:189-195
219. Bini A, Fenoglio JJ Jr, Meas-Tejada R, Kudryk B, Kaplan KL (1989) Identification of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Atherosclerosis 9:109-121
220. Sjoland H, Eitzman DT, Gordon D, Westrick R, Nabel EG, Ginsburg D (2000) Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 20:846-852
221. Eitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D (2000) Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in mouse carotid artery. Blood 96: 4212-4215
222. Hasebstab D, Lea H, Clowes AW (2000) Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. Arterioscler Thromb Vasc Biol 20:853-859
223. Kaikita K, Ogawa H, Yasue H, Takeya M, Takahashi K, Saito T, Hayashi K, Horiuchi K, Takizawa A, Kamikubo Y, Nakamura S (1997) Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol 17:2232-2237
224. Ardissino D, Merlini PA, Arlens R, Coppola R, Bramucci E, Lucreziotti S, Repetto A, Fetiveau R, Mannucci PM (2000) Tissue factor in human coronary atherosclerotic plaques. Clin Chim Acta 291:235-240
225. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shanh PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562-1569
226. Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K (1999) Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol 188:180-188
227. Hamsten A, Wiman B, de Faire U, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563
228. Masuda T, Yasue H, Ogawa H, Misumi I, Sakamoto T, Okubo H, Miyao Y, Kato H (1992) Plasma plasminogen activator inhibitor and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina. Am Heart J 124:314-319
229. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kasmikubo Y, Nakamura S (1997) Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 134:253-259
230. Soejima H, Ogawa H, Yasue H, Kaikita K, Nishimura M, Misumi K, Nakamura S, Tsuji I, Kumeda K (1999) Heightened tissue factor-associated tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 99:2908-2913
231. Aikawa M, Voglic SJ, Sugiyama S, Rabkin E, Taubman MB, Fallon JT, Libby P (1999) Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation 100:1215-1222
232. Hasenstab D, Lea H, Hart CE, Lok S, Clowes AW (2000) Tissue factor overexpression in rat arterial neointima models. Thrombosis and progression of advanced atherosclerosis. Circulation 101:2651-2657
233. Girard TJ, Warron LA, Novotny KF, Likert KM, Brown SG, Miletich JP, Broze GJ Jr (1989) Functional significance of the Kunitz type inhibitory domain of lipoprotein-associated coagulation inhibitor. Nature 338:518-520
234. Atsuchi N, Nishida T, Marutsuka K, Asada Y, Kamikubo Y, Takeshita A, Ueno H (2001) Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries. Circulation 103:570-575
235. Ragni M, Golino P, Cirillo P, Scognamiglio A, Pior O, Esposito N, Battaglia C, Botticelia F, Ponticelli P, Ramunno L, Chiariello M (2000) Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. Circulation 102:113-117
236. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK (1986) Regional accumulation of T cells, macrophages, smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131-138
237. Lichtman AH, Cybulsky M, Luscinskas FW (1996) Immunology of atherosclerosis: the promise of mouse models. Am J Pathol 149:351-357
238. Fortun A, Khalil A, Gagne D, Douziech N, Kuntz C, Jay-Gerin J-P, Dupuis G, Fulop T Jr (2001) Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 156:11-21
239. Drew AF, Tipping PG (1995) T helper cell infiltration and foam cell proliferation are early events in the development of atherosclerosis in cholesterol-fed atheroscerosis. Arterioscler Thromb Vasc Biol 15:1563-1568
240. Fyfe AI, Qiao J-H, Lusis AJ (1994) Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 94:2516-2520
241. Desurmont C, Caillaud J-M, Emmanuel F, Bennot P, Fruchart JC, Castro G, Branellec D, Heard J-M, Duverger N (2000) Complete atherosclerosis regression after human apoE gene transfer in apoE-deficient/nude mice. Arterioscler Thromb Vasc Biol 20:435-442
242. Danksy HM, Charlton SA, Harper MMG, Smith JD (1997) T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 94:4642-4646
243. -/- mice. J Clin Invest 100:1575-1580
244. Emeson EE, Shen M-L, Bell CGH, Qureshi A (1996) Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol 149:675-685
245. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy J-Y, Pober JS, Libby P (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94:1931-1936
246. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394:200-203
247. Häkkinen T, Karkola K, Ylä-Herttuala S (2000) Macrophages, smooth muscle cells, endothelial crells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (FcγRIII). Virchows Arch 437:396-405
248. Bobryshev YV, Lord RSA (1995) S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res 29:689-696
249. Bobryshev YV, Lord RSA, Rainer S, Jamal OS, Munro VF (1996) Vascular dendritic cells and atherosclerosis. Pathol Res Pract 192:462-467
250. Bobryshev YV, Watanabe T (1997) Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis. J Submicrosc Cytol Pathol 29:209-211
251. Bobryshev YV, Lord RSA, Watanabe T (1997) Structural peculiarities of vascular dendritic cell tubulovesicular system in human atherosclerotic aorta. J Submicrosc Cytol Pathol 29:553-561
252. Bobryshev YV, Ikezawa T, Watanabe T (1997) Formation of Birbeck granule-like structures in vascular dendritic cells in human atherosclerotic aorta. Lag-antibody to epidermal Langerhans cells recognizes cells in the aortic wall. Atherosclerosis 133:193-202
253. Bobryshev YV (2000) Dendritic cells and their involvement in atherosclerosis. Curr Opin Lipidol 11:511-517
254. Millonig G, Niederegger H, Rabl W, Hochleitner BW, Hoefer D, Romani N, Wick G (2001) Network of vascular-asssociated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 21:503-508
255. Liu Y-J (2001) Dendritic cell subsets and lineages, their functions in innate and adoptive immunity. Cell 106:259-262
256. Bobryshev YV, Watanabe T (1997) Subset of vascular dendritic cells transforming into foam cells in human atherosclerotic lesions. Cardiovasc Pathol 6:321-331
257. Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106:263-266
258. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M (2001) Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 7:382-383
259. Raines EW, Ross R (1993) Smooth muscle cells and the pathogenesis of lesions of atherosclerosis. Br Heart J 69 (Suppl):S30-S37
260. Inaba T, Gotoda T, Ishibashi S, Harada K, Ohsuga J-I, Ohashi K, Yazaki Y, Yamada N (1996) Transcription factor PU.1 mediates induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypic change to phagocytic cells. Mol Cell Biol 16:2264-2273.
261. Inaba T, Gotoda T, Harada K, Shimada M, Ohsuga J, Ishibashi S, Yazaki Y, Yamada N (1995) Induction of sustained expression of protooncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblastic growth factor, and its suppression by interferon-γ and macrophage colony-stimulating factor in human aortic medial smooth muscle cells. J Clin Invest 95:1133-1139
262. Inaba T, Yamada N, Gotoda T, Shimada H, Shimada M, Momomura K, Kadowaki T, Motoyoshi K, Tsukada T, Morisaki N, Saito Y, Yoshida S, Yazaki Y, Takaku F, Yamada N (1992) Expression of M-CSF receptor encoded by c-fms on smooth muscle cells derived from arteriosclerotic lesion. J Biol Chem 267:5693-5699
263. Lehtotainen P, Takeya M, Ylä-Herttuala S (2000) Retrovirus-mediated, stable scavenger-receptor gene transfer leads to functional endocytotic receptor expression, foam cell formation, and increased susceptibility to apoptosis in rabbit aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 20:52-60
264. Matsumoto K, Hirano KI, Nozaki S, Takamoto A, Nishida M, Nakagawa-Toyama Y, Janabi MY, Ohya T, Yamashita S, Matsuzawa Y (2000) Expression of cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-γ, which regulates gain of Mφ-like phenotype in vitro, and its implication in atherogenesis. Arterioscler Thromb Vasc Biol 20:1027-1032
265. Ricciarelli R, Zingg J-M, Azzi A (2000) Vitamin E reduced the uptake of oxidized LDL by inhibiting scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102:82-87
266. Murao K, Imachi H, Sayo Y, Hosokawa H, Sato M, Ishida T, Nakano T, Kodama T, Sasaguri Y, Takahara J (1999) A product of growth arrest-specific gene 6 modulates scavenger receptor expression in human vascular smooth muscle cells. FEBS Lett 459:363-366
267. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto N, Kita T (1999) Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110-3117
268. Iwasa S, Fan J, Shimokawa T, Nagata M, Watanabe T (1999) Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 146:93-100